IOVANCE BIOTHERAPEUTICS, INC. Other Preferred Stock Dividends and Adjustments
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Other Preferred Stock Dividends and Adjustments of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherPreferredStockDividendsAndAdjustments · last filed 2019-02-28
- IOVANCE BIOTHERAPEUTICS, INC. other preferred stock dividends and adjustments for the quarter ending 2017-12-31 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. other preferred stock dividends and adjustments for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. other preferred stock dividends and adjustments for the quarter ending 2016-12-31 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. other preferred stock dividends and adjustments for the quarter ending 2016-09-30 was $49.45M.
- IOVANCE BIOTHERAPEUTICS, INC. other preferred stock dividends and adjustments for fiscal 2018 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. other preferred stock dividends and adjustments for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- IOVANCE BIOTHERAPEUTICS, INC. other preferred stock dividends and adjustments for fiscal 2016 was $49.45M.
- IOVANCE BIOTHERAPEUTICS, INC. other preferred stock dividends and adjustments for fiscal 2015 was $0.00.
| Period end | Other Preferred Stock Dividends and Adjustments 0 month | Other Preferred Stock Dividends and Adjustments 3 month | Other Preferred Stock Dividends and Adjustments 6 month | Other Preferred Stock Dividends and Adjustments 9 month | Other Preferred Stock Dividends and Adjustments 12 month | Other Preferred Stock Dividends and Adjustments 12 month as first filed | Other Preferred Stock Dividends and Adjustments 72 month | Other Preferred Stock Dividends and Adjustments 78 month |
|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-02-28 | |||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $0.00 derived: sum of 2 quarters · filed 2019-02-28 | $0.00 10-K · filed 2019-02-28 | |||||
| 2017-09-30 | $0.00 10-Q · filed 2017-11-02 | $0.00 10-Q · filed 2017-11-02 | ||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $49.45M derived: sum of 2 quarters · filed 2019-02-28 | $49.45M 10-K · filed 2019-02-28 | |||||
| 2016-09-30 | $49.45M 10-Q · filed 2017-11-02 | $49.45M 10-Q · filed 2017-11-02 | ||||||
| 2016-08-16 | $49.50M 10-Q · filed 2016-11-04 | |||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $0.00 derived: sum of 2 quarters · filed 2018-03-12 | $0.00 10-K · filed 2018-03-12 | |||||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-04 | $0.00 10-Q · filed 2016-11-04 | ||||||
| 2014-12-31 | $0.00 10-K · filed 2017-03-09 | |||||||
| 2014-03-31 | $8.46M 10-Q · filed 2014-05-14 | |||||||
| 2013-12-31 | $8.46M 10-K · filed 2016-03-11 | -$8.46M 10-K · filed 2014-03-28 | -$8.46M 10-K · filed 2014-03-28 | |||||
| 2012-12-31 | $0.00 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |